摘要
结直肠癌是最常见的恶性肿瘤之一,全球发病率位居第三。2023年6月,第59届美国临床肿瘤学会年会在美国召开。会议公布了多项结直肠癌治疗的研究成果,为临床治疗指引方向。本文就本届会议上转移性结直肠癌免疫和靶向治疗领域的重要研究进展作整理报道。
Colorectal cancer is one of the most prevalent malignancies,with the third-highest incidence rate worldwide.In June 2023,the 59th annual meeting of the American Society of Clinical Oncology took place in the United States.At the meeting,several research results on colorectal cancer treatment were announced to guide the direction of clinical practice.This article provides a summary of significant research advances in the field of immunotherapy and targeted therapies for metastatic colorectal cancer that were presented at this conference.
作者
陆依儿
翁姗姗
袁瑛
Lu Yier;Weng Shanshan;Yuan Ying(Department of Medical Oncology,Key Laboratory of Cancer Prevention and Intervention,Ministry of Education,the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310009,China;Cancer Institute,Key Laboratory of Cancer Prevention and Intervention,Ministry of Education,the Second Affi liated Hospital,Zhejiang University School of Medicine,Hangzhou 310009,China;Cancer Center,Zhejiang University,Hangzhou 310058,China)
出处
《实用肿瘤杂志》
CAS
2023年第4期312-317,共6页
Journal of Practical Oncology
基金
浙江省重点研发计划(2021C03125)。
关键词
转移性结直肠癌
免疫治疗
靶向治疗
美国临床肿瘤学会
metastatic colorectal cancer
immunotherapy
targeted therapy
American Society of Clinical Oncology
